The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot.
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2013
At a glance
- Drugs Ranolazine (Primary) ; Amiodarone
- Indications Arrhythmias
- Focus Pharmacokinetics
- Acronyms AVAST
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2011 New trial record